PITTENGER & ANDERSON INC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
PITTENGER & ANDERSON INC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$5,201,991
+1.4%
51,070
+0.5%
0.26%
+6.1%
Q2 2023$5,128,247
+9.7%
50,8200.0%0.25%
+2.1%
Q1 2023$4,675,440
-4.7%
50,820
-6.0%
0.24%
-10.4%
Q4 2022$4,905,230
+34.2%
54,070
+12.5%
0.27%
+23.3%
Q3 2022$3,654,000
+2.6%
48,070
+14.1%
0.22%
+5.3%
Q2 2022$3,563,000
+11.9%
42,145
+16.1%
0.21%
+33.3%
Q1 2022$3,184,000
+22.8%
36,285
+22.4%
0.16%
+30.0%
Q4 2021$2,593,000
+9.8%
29,645
+2.6%
0.12%
+0.8%
Q3 2021$2,362,000
-9.3%
28,881
+1.2%
0.12%
-10.5%
Q2 2021$2,605,000
+6.8%
28,5500.0%0.13%
+0.8%
Q1 2021$2,440,000
-9.5%
28,5500.0%0.13%
-13.7%
Q4 2020$2,696,000
+8.6%
28,5500.0%0.15%
-3.8%
Q3 2020$2,483,000
+8.4%
28,550
+8.9%
0.16%
-1.2%
Q2 2020$2,290,000
+15.0%
26,225
+8.6%
0.16%
-4.7%
Q1 2020$1,991,000
-14.0%
24,150
-1.2%
0.17%
+9.0%
Q4 2019$2,314,000
+8.9%
24,4390.0%0.16%
+1.3%
Q3 2019$2,124,000
-3.7%
24,439
+1.2%
0.15%
-7.3%
Q2 2019$2,205,000
-5.0%
24,1500.0%0.16%
-9.3%
Q1 2019$2,322,000
+12.1%
24,1500.0%0.18%
-4.2%
Q4 2018$2,072,000
-0.4%
24,1500.0%0.19%
+15.9%
Q3 2018$2,081,000
+30.2%
24,150
+14.2%
0.16%
+19.7%
Q2 2018$1,598,000
-6.5%
21,1500.0%0.14%
-8.7%
Q1 2018$1,710,000
-3.7%
21,1500.0%0.15%
-3.2%
Q4 2017$1,776,000
-2.2%
21,1500.0%0.16%
-6.1%
Q3 2017$1,816,000
+2.3%
21,150
-0.6%
0.16%
-2.9%
Q2 2017$1,776,000
+24.7%
21,275
+11.0%
0.17%
+18.9%
Q1 2017$1,424,000
-2.5%
19,175
-4.4%
0.14%
-7.7%
Q4 2016$1,460,000
-16.1%
20,050
-9.1%
0.16%
-19.7%
Q3 2016$1,741,000
-4.3%
22,0500.0%0.19%
-4.0%
Q2 2016$1,819,000
+7.3%
22,050
-5.8%
0.20%
+2.0%
Q1 2016$1,695,000
-26.7%
23,400
-12.9%
0.20%
-31.8%
Q4 2015$2,311,000
-7.0%
26,860
+0.2%
0.29%
-11.9%
Q3 2015$2,485,000
-2.4%
26,800
+3.5%
0.33%
+0.3%
Q2 2015$2,547,000
+10.8%
25,900
+11.2%
0.33%
+10.5%
Q1 2015$2,298,000
+16.4%
23,300
+9.4%
0.30%
+13.8%
Q4 2014$1,974,000
-1.1%
21,300
+0.5%
0.26%
-11.3%
Q3 2014$1,996,000
-0.7%
21,200
-4.5%
0.29%
-1.0%
Q2 2014$2,011,000
+2.2%
22,210
-4.0%
0.30%
+8.0%
Q1 2014$1,967,000
+5.8%
23,1350.0%0.27%
+5.0%
Q4 2013$1,860,000
+4.8%
23,1350.0%0.26%
-8.1%
Q3 2013$1,775,000
+8.5%
23,1350.0%0.28%
+0.7%
Q2 2013$1,636,00023,1350.28%
Other shareholders
NOVARTIS A G shareholders Q2 2022
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders